EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) FOR PATIENTS WITH ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS) IN COVID-19

Date of publication: September 10, 2020

Objectives:

  • To search and synthesize information on the use of Extracorporeal Machine Oxygenation (ECMO) in Acute Respiratory Distress Syndrome in COVID-19 in different countries
  • To search for existing position/recommendation of HTA agencies on ECMO for COVID-19
  • To search and synthesize information on existing evidence on the performance of ECMO in ARDS in terms of the following outcomes:
      • Survival rate
      • Hospitalization days
      • Resolution of symptoms
      • Incidence of adverse events
  • To search and synthesize information on the technical, infrastructural, logistical, and organizational need in implementing ECMO for COVID-19 patients with ARDS.

Evidence summary:

http://bit.ly/ESECMO

Rapid review:

http://bit.ly/RRevECMO

Decision of the Secretary of Health: 

http://bit.ly/DecisionECMO